CA2240394A1 - Recepteur de proteine ob, compositions et procedes associes - Google Patents

Recepteur de proteine ob, compositions et procedes associes

Info

Publication number
CA2240394A1
CA2240394A1 CA 2240394 CA2240394A CA2240394A1 CA 2240394 A1 CA2240394 A1 CA 2240394A1 CA 2240394 CA2240394 CA 2240394 CA 2240394 A CA2240394 A CA 2240394A CA 2240394 A1 CA2240394 A1 CA 2240394A1
Authority
CA
Canada
Prior art keywords
protein
methods
receptor
nucleic acids
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2240394
Other languages
English (en)
Other versions
CA2240394C (fr
Inventor
Ming-Shi Chang
Andrew Avery Welcher
Frederick Addison Fletcher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc.
Ming-Shi Chang
Andrew Avery Welcher
Frederick Addison Fletcher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc., Ming-Shi Chang, Andrew Avery Welcher, Frederick Addison Fletcher filed Critical Amgen Inc.
Priority claimed from PCT/US1997/000128 external-priority patent/WO1997025424A1/fr
Publication of CA2240394A1 publication Critical patent/CA2240394A1/fr
Application granted granted Critical
Publication of CA2240394C publication Critical patent/CA2240394C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2240394 1996-01-04 1997-01-02 Recepteur de proteine ob, compositions et procedes associes Expired - Fee Related CA2240394C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US58282596A 1996-01-04 1996-01-04
US77441496A 1996-12-31 1996-12-31
US08/582,825 1996-12-31
US08/774,414 1996-12-31
PCT/US1997/000128 WO1997025424A1 (fr) 1996-01-04 1997-01-02 Recepteur de proteine ob, compositions et procedes associes

Publications (2)

Publication Number Publication Date
CA2240394A1 true CA2240394A1 (fr) 1997-07-17
CA2240394C CA2240394C (fr) 2008-06-17

Family

ID=29407656

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2240394 Expired - Fee Related CA2240394C (fr) 1996-01-04 1997-01-02 Recepteur de proteine ob, compositions et procedes associes

Country Status (1)

Country Link
CA (1) CA2240394C (fr)

Also Published As

Publication number Publication date
CA2240394C (fr) 2008-06-17

Similar Documents

Publication Publication Date Title
IL125081A0 (en) Ob protein receptor and related compositions and methods
CA2178752A1 (fr) Compositions de proteines ayant subi une modification chimique a l'extremite n-terminale et procedes
WO2001045746A3 (fr) Methodes et compositions permettant de prolonger les demi-vies d'elimination de composes bioactifs
WO1999011791A3 (fr) Recepteurs et ligands de la famille du facteur de necrose tumorale, acides nucleiques codants et agents de liaison associes
CA2285040A1 (fr) Recepteur 5 contenant un domaine de mort
CA2295999A1 (fr) Proteines nik, acides nucleiques et procedes correspondants
EP0871726A4 (fr) Recepteurs chimeres a specificites multiples
IE891542L (en) Peptides having t cell helper activity
JP2000512339A5 (fr)
CA2326389A1 (fr) Polypeptides specifiques a cd19 et cd3 et leurs utilisations
CA2294516A1 (fr) Proteines ikk-.beta., acides nucleiques et procedes
IE892685L (en) Preparation comprising cavitate- or clathrate-forming¹host/guest complexes as contrast agent
IL124831A0 (en) Ob protein derivatives having prolonged half-life
AU2001242749A1 (en) Peptide derivative
CA2229028A1 (fr) Molecules d'acides nucleiques, proteine et peptides associes aux cellules du colon et aux cellules cancereuses du colon
FR2738151B1 (fr) Antagonistes de l'activite oncogenique de la proteine mdm2, et leur utilisation dans le traitement des cancers
WO2001064877A3 (fr) Gene humain de la schizophrenie
WO2001014420A3 (fr) Nouveaux plexines et leurs utilisations
ZA983851B (en) Substituted 3,3-diamino-2-propenenitriles their preparation and use
CA2294566A1 (fr) Proteines ikk-.alpha., acides nucleiques et procedes
CA2294476A1 (fr) Recepteurs de semaphorine
WO1999014241A3 (fr) Traitement d'affections liees aux fonctions immunitaires et compositions correspondantes
CA2064814A1 (fr) Recepteur de facteur de stimulation de colonies de macrophages-granulocytes
ATE271394T1 (de) Hybride zusammensetzungen für intrazellulaire verabreichung
WO1994026891A3 (fr) Ligands purifies de flt3 de mammiferes et leurs agonistes/antagonistes

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed